Header Logo

Connection

Ralf Janknecht to DNA-Binding Proteins

This is a "connection" page, showing publications Ralf Janknecht has written about DNA-Binding Proteins.
Connection Strength

7.814
  1. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer. Int J Oncol. 2020 12; 57(6):1319-1332.
    View in: PubMed
    Score: 0.554
  2. Relationship between ETS Transcription Factor ETV1 and TGF-ß-regulated SMAD Proteins in Prostate Cancer. Sci Rep. 2019 06 03; 9(1):8186.
    View in: PubMed
    Score: 0.504
  3. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1. J Clin Invest. 2016 Feb; 126(2):706-20.
    View in: PubMed
    Score: 0.398
  4. 14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer. Cancer Res. 2013 Aug 15; 73(16):5110-9.
    View in: PubMed
    Score: 0.334
  5. ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells. Oncol Rep. 2013 Jan; 29(1):306-14.
    View in: PubMed
    Score: 0.318
  6. ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors. Biochim Biophys Acta. 2012 Aug; 1826(1):1-12.
    View in: PubMed
    Score: 0.305
  7. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81. Cancer Res. 2009 Oct 15; 69(20):8102-10.
    View in: PubMed
    Score: 0.258
  8. Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors. J Cell Biochem. 2008 Oct 15; 105(3):866-74.
    View in: PubMed
    Score: 0.241
  9. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem Biophys Res Commun. 2007 Aug 03; 359(3):742-6.
    View in: PubMed
    Score: 0.219
  10. Diversity within the JMJD2 histone demethylase family. Biochem Biophys Res Commun. 2007 Feb 23; 353(4):973-7.
    View in: PubMed
    Score: 0.213
  11. Repression of transcription by TSGA/Jmjd1a, a novel interaction partner of the ETS protein ER71. J Cell Biochem. 2006 Sep 01; 99(1):319-29.
    View in: PubMed
    Score: 0.208
  12. Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer. Gynecol Oncol. 2005 Feb; 96(2):368-73.
    View in: PubMed
    Score: 0.187
  13. Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu. J Biol Chem. 2004 Apr 09; 279(15):14909-16.
    View in: PubMed
    Score: 0.174
  14. Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf. Mol Cell Biol. 2004 Jan; 24(1):25-35.
    View in: PubMed
    Score: 0.173
  15. Upregulation of the matrix metalloproteinase-1 gene by the Ewing's sarcoma associated EWS-ER81 and EWS-Fli-1 oncoproteins, c-Jun and p300. FEBS Lett. 2003 Oct 09; 553(1-2):104-8.
    View in: PubMed
    Score: 0.170
  16. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol Cell Biol. 2003 Sep; 23(17):6243-54.
    View in: PubMed
    Score: 0.169
  17. HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81. J Biol Chem. 2003 Nov 07; 278(45):44377-84.
    View in: PubMed
    Score: 0.169
  18. Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1). Oncogene. 2003 Feb 06; 22(5):746-55.
    View in: PubMed
    Score: 0.163
  19. Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A. J Biol Chem. 2002 Nov 08; 277(45):42669-79.
    View in: PubMed
    Score: 0.158
  20. Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81. J Cell Biochem. 2002; 86(1):174-83.
    View in: PubMed
    Score: 0.151
  21. HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene. 2001 Sep 27; 20(43):6215-24.
    View in: PubMed
    Score: 0.148
  22. Cell type-specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2. J Biol Chem. 2001 Nov 09; 276(45):41856-61.
    View in: PubMed
    Score: 0.148
  23. Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300. Mol Cell Biol. 2000 Oct; 20(19):7300-10.
    View in: PubMed
    Score: 0.138
  24. Activation of Smad1-mediated transcription by p300/CBP. Biochim Biophys Acta. 1999 Dec 23; 1489(2-3):354-64.
    View in: PubMed
    Score: 0.131
  25. TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300. Genes Dev. 1998 Jul 15; 12(14):2114-9.
    View in: PubMed
    Score: 0.119
  26. Transcriptional activity and constitutive nuclear localization of the ETS protein Elf-1. FEBS Lett. 1997 May 12; 408(1):47-51.
    View in: PubMed
    Score: 0.109
  27. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J. 1997 Apr 01; 16(7):1620-7.
    View in: PubMed
    Score: 0.108
  28. Activation of the Sap-1a transcription factor by the c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase. J Biol Chem. 1997 Feb 14; 272(7):4219-24.
    View in: PubMed
    Score: 0.107
  29. MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP. Biochem Biophys Res Commun. 1996 Nov 21; 228(3):831-7.
    View in: PubMed
    Score: 0.106
  30. The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA. Oncogene. 1996 Oct 17; 13(8):1745-54.
    View in: PubMed
    Score: 0.105
  31. ETS transcription factor ERG cooperates with histone demethylase KDM4A. Oncol Rep. 2016 Jun; 35(6):3679-88.
    View in: PubMed
    Score: 0.101
  32. Analysis of the ERK-stimulated ETS transcription factor ER81. Mol Cell Biol. 1996 Apr; 16(4):1550-6.
    View in: PubMed
    Score: 0.101
  33. SAP1a is a nuclear target of signaling cascades involving ERKs. Oncogene. 1995 Mar 16; 10(6):1209-16.
    View in: PubMed
    Score: 0.094
  34. Co-occurrence of CArG boxes and TCF sites within viral genomes. Biochem Biophys Res Commun. 1994 Nov 30; 205(1):545-51.
    View in: PubMed
    Score: 0.092
  35. Functional dissection of the transcription factor Elk-1. Oncogene. 1994 Apr; 9(4):1273-8.
    View in: PubMed
    Score: 0.088
  36. Stimulation of ß-catenin and colon cancer cell growth by the KDM4B histone demethylase. Int J Oncol. 2014 Apr; 44(4):1341-8.
    View in: PubMed
    Score: 0.087
  37. Gene regulation by Ets proteins. Biochim Biophys Acta. 1993 Dec 23; 1155(3):346-56.
    View in: PubMed
    Score: 0.086
  38. Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J. 1993 Dec 15; 12(13):5097-104.
    View in: PubMed
    Score: 0.086
  39. C-terminal phosphorylation of the serum-response factor. Eur J Biochem. 1993 Sep 01; 216(2):469-75.
    View in: PubMed
    Score: 0.085
  40. Affinity purification of histidine-tagged proteins transiently produced in HeLa cells. Gene. 1992 Nov 16; 121(2):321-4.
    View in: PubMed
    Score: 0.080
  41. Elk-1 protein domains required for direct and SRF-assisted DNA-binding. Nucleic Acids Res. 1992 Jul 11; 20(13):3317-24.
    View in: PubMed
    Score: 0.078
  42. Identification of multiple SRF N-terminal phosphorylation sites affecting DNA binding properties. EMBO J. 1992 Mar; 11(3):1045-54.
    View in: PubMed
    Score: 0.076
  43. Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus. Proc Natl Acad Sci U S A. 1991 Oct 15; 88(20):8972-6.
    View in: PubMed
    Score: 0.074
  44. hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins. Clin Orthop Relat Res. 2004 Sep; (426):64-8.
    View in: PubMed
    Score: 0.045
  45. On the road to immortality: hTERT upregulation in cancer cells. FEBS Lett. 2004 Apr 23; 564(1-2):9-13.
    View in: PubMed
    Score: 0.044
  46. Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Oncogene. 2003 Sep 11; 22(39):8042-7.
    View in: PubMed
    Score: 0.042
  47. TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses. Oncogene. 2002 Aug 22; 21(37):5783-90.
    View in: PubMed
    Score: 0.039
  48. Modulation of transforming growth factor beta (TGFbeta)/Smad transcriptional responses through targeted degradation of TGFbeta-inducible early gene-1 by human seven in absentia homologue. J Biol Chem. 2002 Aug 23; 277(34):30754-9.
    View in: PubMed
    Score: 0.039
  49. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene. J Cell Biochem. 2002; 87(2):233-41.
    View in: PubMed
    Score: 0.038
  50. Nuclear fusion of signaling pathways. Science. 1999 Apr 16; 284(5413):443-4.
    View in: PubMed
    Score: 0.031
  51. Signalling pathways: jack of all cascades. Curr Biol. 1996 Jan 01; 6(1):16-9.
    View in: PubMed
    Score: 0.025
  52. High affinity DNA binding of native full length c-Myb and differential proteolytic sensitivity of its N- and C-terminal domains. Oncogene. 1995 Jun 01; 10(11):2221-8.
    View in: PubMed
    Score: 0.024
  53. Signal integration at the c-fos promoter. Carcinogenesis. 1995 Mar; 16(3):443-50.
    View in: PubMed
    Score: 0.023
  54. Transcriptional repression mediated by the serum response factor. FEBS Lett. 1995 Jan 02; 357(1):45-9.
    View in: PubMed
    Score: 0.023
  55. Heterogeneity of ternary complex factors in HeLa cell nuclear extracts. J Biol Chem. 1994 Sep 16; 269(37):23310-7.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.